The pharmaceutical industry is undergoing significant transformation, primarily driven by the increasing integration of artificial intelligence (AI) in drug research and development (R&D). Sanofi, a key player in the sector, exemplifies this trend by optimizing drug target discovery through AI. Simultaneously, strategic collaborations, such as the one between Pfizer and an Austrian institute, aim to develop innovative AI models. However, these advances are accompanied by regulatory and ethical challenges, necessitating a rapid adaptation of legislative frameworks.
Débloquez l'Analyse Complète
Accédez instantanément à nos insights exclusifs générés par IA, basés sur l'agrégation de centaines de sources sectorielles.
